Incidence and predictors of major bleeding among patients receiving apixaban or aspirin for subclinical atrial fibrillation: insights from the ARTESiA sub-analysis

Back

EHRA Premium Access

Incidence and predictors of major bleeding among patients receiving apixaban or aspirin for subclinical atrial fibrillation: insights from the ARTESiA sub-analysis

Session: Clinical aspects in atrial fibrillation care

Topic: Oral Anticoagulation

Speaker: Doctor D. Siegal (Ottawa, CA)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Deborah Michelle Siegal

University of Ottawa, Ottawa (Canada)

0 follower

5 more presentations in this session

Association between atrial fibrillation and dementia, with a particular focus on early-onset dementia: a longitudinal population-based study in catalonia, spain

Speaker: Mr J. Rodriguez Garcia (Hospitalet De Llobregat, ES)

The impact of timing and order of disease development on the risk of mortality in atrial fibrillation and heart failure patients

Speaker: Ms A. Zandijk (Groningen, NL)

Randomized comparison of left atrial appendage closure and oral anticoagulation after catheter ablation for atrial fibrillation: subanalysis of AF type

Speaker: Doctor C. Tondo (Monzino, IT)

Multimorbidity and risk of atrial fibrillation in the Lifelines Cohort

Speaker: Miss C. Van Deutekom (Groningen, NL)

Comparison of CHA2DS2-VA and CHA2DS2-VASc scores for predicting residual risk of stroke and adverse outcomes in anticoagulated patients with atrial fibrillation: a report from a European registry

Speaker: Doctor D. Mei (Modena, IT)

Access the full session

Clinical aspects in atrial fibrillation care

Speakers: Doctor D. Siegal, Mr J. Rodriguez Garcia, Ms A. Zandijk, Doctor C. Tondo, Miss C. Van Deutekom...

Access

Video

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources